Michael Holder Email and Phone Number
Michael Holder work email
- Valid
- Valid
Michael Holder personal email
- Valid
Michael Holder phone numbers
Michael Holder has 30+ years of diverse business experience having held 8 board, 4 CEO, 2 PE/venture capital executive, and 5 CFO positions for both public and private companies in the biotech, medtech, pharma, wellness and health tech industries. Mr. Holder’s areas of expertise include corporate strategy, fundraising, business development, M&A, corporate governance, sales & earnings improvement, regulatory, reimbursement, and infrastructure development in public companies on the NASDAQ, ASX, and TSX as well as high growth investor backed private companies. Mr. Holder’s experience includes leadership of a $250M private investment company; leadership, P&L and sales responsibility for a $325M med tech and IT solution hospital supply company; as well as completion of $2.5B+ in M&A transactions, nearly $2B in equity & debt capital transactions including two IPOs, a reverse merger public offering, and 3 corporate exits including a $225M sale as Chairman/CEO.Mr. Holder is currently the CEO of Sensable Health a wellness program that incorporates biology, machine learning, and artificial intelligence into a program to achieve weight loss and healthspan improvement. Mr. Holder is also a board member and Audit Committee Chair of Cytek Biosciences Inc. (NASDAQ:CKTB), a leading cell analysis solutions company; and board director of Keyron Inc., a London, based early-stage medical device company. Mr. Holder is also a Principal in Gloria Consulting Partners LLC, an executive management, business strategy and development, and M&A consulting company.Mr. Holder previously served as CEO of Longevita Bio Pharma Partners, LLC, an advisory firm providing services to global life science and medical device companies. Prior to that, Mr. Holder was CEO and Portfolio Manager of Carolina Longevity Institute, Inc. (CLI), a $250M private investment fund. At CLI, Mr. Holder was responsible for transacting investments and advising portfolio companies in the biotech, health and wellness, and med tech industries. At Organ Transport Systems, Inc., a medical device and biologic company, Mr. Holder was Executive Chairman/CEO and led the recruitment of an industry leading board and completed 4 rounds of fundraising and a Company sale. At Cyphre, Inc. a healthcare cybersecurity company, Mr. Holder assumed a board leadership role in its sale to RigNet Inc. (NASDAQ:RNET). Mr. Holder holds an M.B.A. from the Wharton School, a B.S. in Business Administration from the University of North Carolina (subsequently serving on the Board of Visitors) and previously obtained his CPA.
Sensable Health
View-
Chief Executive OfficerSensable Health Jul 2024 - PresentDenver, Colorado, UsSensable Health offers a wellness solution that incorporates biology, AI, and machine learning to improve and optimize individual healthspan, realize sustainable weight loss, improve nutrition, improve sleep, and lower stress.
-
Board Member; Chair Audit CommitteeCytek Biosciences Jun 2024 - PresentFremont, Ca, UsCytek® Biosciences Inc. (NASDAQ:CTKB) is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before. As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.Websitehttps://cytekbio.com/IndustryBiotechnology ResearchCompany size501-1,000 employees -
Board MemberKeyron Medical Technology Dec 2022 - PresentKeyron is a London based, medical device and technology platform company developing and commercializing a highly effective treatment of metabolic diseases. Keyron’s patented ForePass™ is an innovative medical device designed to safely reverse type-2 diabetes, as well as NASH, and obesity. The company has already demonstrated a full reversal of insulin resistance in animal studies, and recently published the results in The Lancet EBioMedicine. Keyron has upcoming clinical trials in South America and aims to then carry out further clinical trials in the USA. Its founders, directors, advisors and investors include some of the most well-known and cited professors and KOLs worldwide in the metabolic diseases space. The company is backed by multiple institutional investors based in the USA and EMEA. -
Chief Financial OfficerAvita Medical 2021 - 2023Santa Clarita, California, UsAVITA Medical is a publicly listed (NASDAQ: RCEL, ASX:AVH) regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, acute and chronic wounds, vitiligo, cell and gene therapy, and aesthetics indications. AVITA Therapeutics’ patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment. -
Chief Financial OfficerImmunecyte, Inc. 2020 - 2021Irvine, California, UsGlobal clinical stage biopharmaceutical company with innovative cell and gene immune-oncology therapeutics, including CAR-T, hiTCR-T and CAR-NK plaftorms with 20 overall indications, as well as cGMP facilities and operations in China, India and the US. -
Chief Executive OfficerLongevita Biopharma Partners, Llc 2019 - 2021Advisory firm providing investment and services to global, clinical-stage life science companies, assuming CXO and board roles, and advising on strategy, fundraising, business development, commercial planning, drug development and regulatory matters.
-
Chairman Of The BoardLimitless Research, Inc. 2018 - 2020As non-executive Chairman, led supplement, nutritional product, and wellness company board through private funding round and pre-clinical research activities
-
Chief Executive Officer And Portfolio ManagerCarolina Longevity Institute 2017 - 2019Private investment company with a mandate to invest in, acquire and operate biotech, pharma, and medtech companies that improve human health and longevity. Carolina Longevity advises its portfolio companies relative to strategy, M&A, financings, research & regulatory matters, and corporate governance. -
Board MemberCyphre Security Solutions, Llc 2015 - 2017Provider of a cyber-security platform created for advanced enterprise data protection. The company's hardware-based encryption features low latency protection for files at rest and in transit for both public and private cloud enabling companies to have higher levels of granularity and control than previously seen in the market.Led board through CEO transition and sale of company to RigNet (NASDAQ:RNET) -
Chairman And Chief Executive OfficerOrgan Transport Systems, Inc. 2005 - 2017Medical device and pharma solution company which developed the LifeCradle device and solution that preserves, monitors and transports organs to be used in transplantation.
-
Vp Sales, Operations And Finance (General Manager)Premier Inc. 2002 - 2004Charlotte, Nc, UsMedical equipment and IT product and services subsidiary of leading group purchasing organization named to the Fortune Best Company to Work List (100 best companies to work for in the United States). -
Chief Financial OfficerPremier Inc. 2000 - 2002Charlotte, Nc, Us
Michael Holder Skills
Michael Holder Education Details
-
The Wharton SchoolCorporate Strategy And Finance -
Unc Kenan-Flagler Business SchoolBachelor Of Business Administration - Bba
-
Harvard Business SchoolExecutive Education: Making Corporate Boards More Effective
Frequently Asked Questions about Michael Holder
What company does Michael Holder work for?
Michael Holder works for Sensable Health
What is Michael Holder's role at the current company?
Michael Holder's current role is CEO and Board Director in the Life Sciences, Medical Devices, Wellness, and Healthcare (CEO of Sensable Health; and non-executive board director at Cytek Biosciences (NASDAQ:CTKB) and Keyron Medical).
What is Michael Holder's email address?
Michael Holder's email address is mi****@****ail.com
What is Michael Holder's direct phone number?
Michael Holder's direct phone number is +197261*****
What schools did Michael Holder attend?
Michael Holder attended The Wharton School, Unc Kenan-Flagler Business School, Harvard Business School.
What skills is Michael Holder known for?
Michael Holder has skills like Leadership, Auditing, Presentation Skills, Business Acquisition, Leadership Skills, Team Building, Accounting, Sec Financial Reporting, Generally Accepted Accounting Principles, Budgeting And Forecasting, Budget, Financials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial